Literature DB >> 17955503

Prostate inflammation and its potential impact on prostate cancer: a current review.

Jessica Haverkamp1, Bridget Charbonneau, Timothy L Ratliff.   

Abstract

Recent studies have identified a role for inflammation in the development and progression of several cancers, such as liver, stomach and the large intestine. Data from several studies has shown correlations between soluble inflammatory mediators, such as cytokines, chemokines and growth factors. However, a direct relationship between inflammation and prostate cancer has yet to be identified. Two major hurdles currently exist which limit the study of this relationship are first that animal models available for studying prostate inflammation are limited, and secondly that relatively little is known about the inflammatory response in the prostate. Here we first review the data demonstrating a correlation between inflammation and prostate cancer as well as review what is currently known about the inflammatory response in the prostate and the impact this inflammation has on the prostate tissue. 2007 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 17955503     DOI: 10.1002/jcb.21536

Source DB:  PubMed          Journal:  J Cell Biochem        ISSN: 0730-2312            Impact factor:   4.429


  32 in total

Review 1.  Vitamin D and cancer: a review of molecular mechanisms.

Authors:  James C Fleet; Marsha DeSmet; Robert Johnson; Yan Li
Journal:  Biochem J       Date:  2012-01-01       Impact factor: 3.857

2.  Physical activity after diagnosis and risk of prostate cancer progression: data from the cancer of the prostate strategic urologic research endeavor.

Authors:  Erin L Richman; Stacey A Kenfield; Meir J Stampfer; Alan Paciorek; Peter R Carroll; June M Chan
Journal:  Cancer Res       Date:  2011-05-24       Impact factor: 12.701

Review 3.  [The significance of chronic prostatitis for the etiopathology of prostate cancer].

Authors:  D Wittschieber; S Schenkenberg; M Dietel; A Erbersdobler
Journal:  Urologe A       Date:  2010-08       Impact factor: 0.639

4.  Vigorous Physical Activity Is Associated with Lower Risk of Metastatic-Lethal Progression in Prostate Cancer and Hypomethylation in the CRACR2A Gene.

Authors:  James Y Dai; Bo Wang; Xiaoyu Wang; Anqi Cheng; Suzanne Kolb; Janet L Stanford; Jonathan L Wright
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2018-11-21       Impact factor: 4.254

5.  An inducible model of abacterial prostatitis induces antigen specific inflammatory and proliferative changes in the murine prostate.

Authors:  Jessica M Haverkamp; Bridget Charbonneau; Scott A Crist; David K Meyerholz; Michael B Cohen; Paul W Snyder; Robert U Svensson; Michael D Henry; Hsing-Hui Wang; Timothy L Ratliff
Journal:  Prostate       Date:  2011-01-12       Impact factor: 4.104

Review 6.  Future directions in the prevention of prostate cancer.

Authors:  Ian M Thompson; April B Cabang; Michael J Wargovich
Journal:  Nat Rev Clin Oncol       Date:  2013-11-26       Impact factor: 66.675

7.  An aberrant prostate antigen-specific immune response causes prostatitis in mice and is associated with chronic prostatitis in humans.

Authors:  Yafei Hou; Jason DeVoss; Vinh Dao; Serena Kwek; Jeffrey P Simko; Douglas G McNeel; Mark S Anderson; Lawrence Fong
Journal:  J Clin Invest       Date:  2009-07       Impact factor: 14.808

8.  Propionibacterium acnes infection induces upregulation of inflammatory genes and cytokine secretion in prostate epithelial cells.

Authors:  Johanna B Drott; Oleg Alexeyev; Patrik Bergström; Fredrik Elgh; Jan Olsson
Journal:  BMC Microbiol       Date:  2010-04-26       Impact factor: 3.605

Review 9.  Current status of thalidomide and CC-5013 in the treatment of metastatic prostate cancer.

Authors:  Tristan M Sissung; Silja Thordardottir; Erin R Gardner; William D Figg
Journal:  Anticancer Agents Med Chem       Date:  2009-12       Impact factor: 2.505

10.  Iron behaving badly: inappropriate iron chelation as a major contributor to the aetiology of vascular and other progressive inflammatory and degenerative diseases.

Authors:  Douglas B Kell
Journal:  BMC Med Genomics       Date:  2009-01-08       Impact factor: 3.063

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.